§ PHARMACEUTICALS
USD · PharmaceuticalsBTMD
BIOTE CORP -A
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
42 increased/new, 20 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| 325 CAPITAL LLC | 4.5M | 2.2% | ±0% |
| Bandera Partners LLC | 2.1M | 1.3% | −10% |
| BlackRock, Inc. | 1.7M | 0.0% | −2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | n/a | n/a |
| State Street | 647K | 0.0% | +8% |
| Geode Capital Management | 616K | 0.0% | −1% |
◇ AC INTELLIGENCE
Top institutional owners for BTMD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER58.8% · 0 holders
OTHER28.7% · 51 holders
PASSIVE / INDEX6.2% · 7 holders
DEALER / BANK3.8% · 15 holders
QUALITY / COMPOUNDER1.7% · 6 holders
SYSTEMATIC / QUANT0.7% · 2 holders
INCOME / DEFENSIVE0.1% · 3 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for BTMD in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention BTMD yet.